| 摘要 |
<p>A method and medicament for treating mixed lineage leukemia; translocated mixed lineage leukemia; translocated mixed lineage leukemia based acute myelogenous leukemia; translocated mixed lineage leukemia based acute lymphoid leukemia; a non-MLL based chronic myeloproliferative disorder, or non-MLL based acute lymphoid leukemia is provided, wherein the active agent used is the GSK-3 inhibitor 7-(2,5-dihydro-4-imidazo[ 1,2-a]pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinylcarbonyl)-pyrrolo[3,2,1 jk][1,4]benzodiazepine or a pharmaceutically acceptable salt or solvate thereof.</p> |
